FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Sep 9, 2016
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on September 9, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- September 9, 2016
- Product Type
- Biologics
View Company Profile
ID · 4bedcd6d-3cde-47d9-855b-e30341e0b7b9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 984810
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 600.14(c)When to report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 26, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 19, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 8, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1063917 - 2018-07-24
- FDA Inspection 898284 - 2014-09-26
- FDA Inspection 800555 - 2012-09-19
- FDA Inspection 658222 - 2010-04-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.